Sep 05, 2019 / 01:10PM GMT
Peter Heinz Costa - Wells Fargo Securities, LLC, Research Division - MD and Senior Analyst
Welcome, everybody. This -- I'm Peter Costa, Wells Fargo's health care services analyst, if you don't know me. We're very pleased to have with us today Anthem. And from Anthem, we have John Gallina, the EVP and CFO of the company. We also have Chris Rigg, who many of you talked to already, VP of Investor Relations and Corporate Finance. And out there is Paige Kerns, Director of IR.
We're going to do this as a fireside chat. You are welcome to ask questions. If you want to throw a question in, try to get my attention by raising your hand or something. There'll also be instructions up on the screen in a little bit on how you can text me a question, and then I'll ask the question for you if you're shy or whatever.
Questions and Answers:
Peter Heinz Costa - Wells Fargo Securities, LLC, Research Division - MD and Senior AnalystSo John, let's get started with IngenioRx, let's talk about that a little bit. You started this transition from Cigna Express to Ingenio
Trustpilot
